Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Buse

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|April 24, 2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialSimon Heller, John Buse, Miles Fisher, et al.
Lancet (London, England)|April 2, 2010
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysisRichard Kahn, Peter Alperin, David Eddy, et al.
Diabetes|April 28, 2011
HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cellsFatima Whitfield-Larry, Ellen F Young, Garrick Talmage, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Proteomic Pathways across Ejection Fraction Spectrum in Heart Failure: an EXSCEL SubstudyAnthony E Peters, Maggie Nguyen, Jennifer B Green, et al.
Diabetes Care|March 21, 2012
Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participantsJosyf C Mychaleckyj, Timothy Craven, Uma Nayak, et al.
Diabetes Care|November 16, 2022
Questionnaire-Based Polyexposure Assessment Outperforms Polygenic Scores for Classification of Type 2 Diabetes in a Multiancestry CohortFarida S Akhtari, Dillon Lloyd, Adam Burkholder, et al.
BMC Health Services Research|May 3, 2008
Development and validation of the Diabetes Numeracy Test (DNT)Mary Margaret Huizinga, Tom A Elasy, Kenneth A Wallston, et al.
Journal of Medical Virology|February 13, 2021
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesityCarolyn T Bramante, John Buse, Leonardo Tamaritz, et al.
The New England Journal of Medicine|November 6, 2012
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh, Michael Domanski, Lynn A Sleeper, et al.
Journal of Clinical Medicine|July 2, 2021
Arguments against the Requirement of a Biological License Application for Human Pancreatic Islets: The Position Statement of the Islets for US Collaborative Presented during the FDA Advisory Committee MeetingPiotr Witkowski, Jon Odorico, Jordan Pyda, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|April 24, 2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialSimon Heller, John Buse, Miles Fisher, et al.
Lancet (London, England)|April 2, 2010
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysisRichard Kahn, Peter Alperin, David Eddy, et al.
Diabetes|April 28, 2011
HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cellsFatima Whitfield-Larry, Ellen F Young, Garrick Talmage, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Proteomic Pathways across Ejection Fraction Spectrum in Heart Failure: an EXSCEL SubstudyAnthony E Peters, Maggie Nguyen, Jennifer B Green, et al.
Diabetes Care|March 21, 2012
Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participantsJosyf C Mychaleckyj, Timothy Craven, Uma Nayak, et al.
Diabetes Care|November 16, 2022
Questionnaire-Based Polyexposure Assessment Outperforms Polygenic Scores for Classification of Type 2 Diabetes in a Multiancestry CohortFarida S Akhtari, Dillon Lloyd, Adam Burkholder, et al.
BMC Health Services Research|May 3, 2008
Development and validation of the Diabetes Numeracy Test (DNT)Mary Margaret Huizinga, Tom A Elasy, Kenneth A Wallston, et al.
Journal of Medical Virology|February 13, 2021
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesityCarolyn T Bramante, John Buse, Leonardo Tamaritz, et al.
The New England Journal of Medicine|November 6, 2012
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh, Michael Domanski, Lynn A Sleeper, et al.
Journal of Clinical Medicine|July 2, 2021
Arguments against the Requirement of a Biological License Application for Human Pancreatic Islets: The Position Statement of the Islets for US Collaborative Presented during the FDA Advisory Committee MeetingPiotr Witkowski, Jon Odorico, Jordan Pyda, et al.
Pageof 3